Comparison of the influence of low dose etomidate and propofol as priming dose on the incidence of etomidate induced myoclonus: a randomised, double-blind clinical trial-Reference-Cited by-同舟云学术

Comparison of the influence of low dose etomidate and propofol as priming dose on the incidence of etomidate induced myoclonus: a randomised, double-blind clinical trial

Published:2021-04 Issue: Volume: Page:
ISSN:0104-0014
Container-title:Brazilian Journal of Anesthesiology (English Edition)
language:en
Short-container-title:Brazilian Journal of Anesthesiology (English Edition)

Author:

Moningi Srilata,Reddy G. Poojitha,Nikhar Sapna Annaji^ORCID,Chikkala Ramakrishna,Kulkarni Dilip Kumar,Ramachandran Gopinath

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Etomidate-® Lipuro is associated with considerably less injection pain in children compared with propofol with added lidocaine;Nyman;Br J Anaesth,2006

2. Pro/con debate: Is etomidate safe in hemodynamically unstable critically ill patients?;Flynn;Critical Care,2012

3. Intravenous Anesthetics;JAAP,2020

4. Midazolam pre-treatment reduces etomidate-induced myoclonic movements;Schwarzkopf;Anaesth Intensive Care,2003

5. Propofol decreases etomidate-related myoclonus in gastroscopy;Liu;Medicine,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose nalmefene pretreatment reduces etomidate-induced myoclonus: A randomized, double-blind controlled trial;Medicine;2023-09-08

2. Comparative assessment of dexmedetomidine and butorphanol for attenuation of etomidate-induced myoclonus: A double-blind, randomised controlled study;Indian Journal of Anaesthesia;2023-09

3. To study the effect of three different doses of dexmedetomidine as premedication on the incidence and severity of etomidate-induced myoclonus;The Indian Anaesthetists Forum;2023

4. Comparison of the Effectiveness of Various Drug Interventions to Prevent Etomidate-Induced Myoclonus: A Bayesian Network Meta-Analysis;Frontiers in Medicine;2022-04-26

5. Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection — a systematic review;Neurologia i Neurochirurgia Polska;2021-12-22